The Collapsed Deal in Çorum: PSV and Seven Million Euros With No Way Out

This summer, at a sports clinic in central Türkiye, a young centre-back from Burkina Faso walked into a medical examination room with a contract almost in his hands. Hours later, he walked out. Nothing signed. Nothing changed in the transfer file. The examination was not passed. The deal collapsed in silence. And in Eindhoven, thousands of kilometres away, the PSV leadership looked at the same piece of paper: an investment of seven million euros hanging in mid-air, with no destination. I have sat in European stands often enough to know that deals collapsing at the medical gateway are never hot news. No goals, no red cards, no moment worth putting on air. But if you follow a club long enough — and I have followed Southeast Asian clubs for more than a decade, from Selangor's dressing room to empty training grounds — you learn that it is precisely these cold stories that hide the real narrative. Goals are loud. A collapsed contract is quiet, and sometimes that quiet travels further than a defeat. Today I write about PSV Eindhoven, about Adamo Nagalo, and about a medical examination that changed everything. Context: When a young centre-back goes looking for a destination To understand why a story like this matters, you need to look at Nagalo's path. About two years ago, PSV signed him from FC Nordsjælland in Denmark, for a fee recorded at around seven million euros. In Eredivisie terms that is not astronomical, but for a young centre-back coming from the Danish league it is a substantial investment. PSV's scouting department saw something: a defender who could develop, who could be resold, who could become a link in the player-trading model that Dutch clubs have operated for years. It is a familiar model. A mid-tier European club buys a young player from a smaller league, gives him a couple of seasons to increase in value, then sells him to a bigger club at double or triple the price. Nordsjælland has long been one of the most efficient development and transit hubs in Nordic football. PSV, in that model, plays the middle-tier buyer — big enough to attract talent, big enough to resell. But the model only works when the player develops on the expected trajectory. Nagalo did not. After roughly two years in Eindhoven, he has made only twelve appearances in a PSV shirt. Twelve. That is the only figure in this entire story that can be called match data, and it says a great deal without needing any complex statistical table. A centre-back with twelve appearances across two seasons is almost certainly not a pillar. He is a back-up option, a rotation piece, a name that appears on the bench more often than on the pitch. That matters, because it shapes how we should read this news. Nagalo's absence — even if it lasts the rest of the season — is not a tactical loss. Nobody has to redraw a tactical diagram because he cannot play. This is not the story of a club losing a pillar. It is the story of a club losing an asset. And that asset, in modern football, is not measured only in minutes on the pitch. It is measured in the books. Core: Seven million euros and twelve appearances Start with the number. Seven million euros is the initial cost. Twelve appearances is what was recovered on the pitch. Put the two side by side and the efficiency ratio is close to zero. In football accounting, every contract has its value spread across the contract length — a process called amortisation. If PSV signed Nagalo on a five-year deal at seven million euros, then each year around one point four million euros of his value is written down on the books. After two years, roughly four million euros of unamortised value remains to be recovered — through a sale, through a paid loan, or by letting him play and increase his value. The first and second routes have just been blocked by a medical examination. The third, with twelve appearances in two years, never truly started. I look at the feet, but I listen to the heart of that kid. In Nagalo's case, the feet did not lie — they said he never touched the rhythm of Eredivisie's top level in this shirt. But the real story is not in the feet. It is in the medical department, the scouting department, and the finance department of one of the biggest clubs in the Netherlands. The move to FK Çorum was seen as almost complete this summer. According to De Telegraaf, reported by PSV-watcher Jeroen Kapteijns, everything collapsed at the medical stage. This is the pivotal point. A failed medical is not just paperwork. It has three overlapping consequences. First, the buyer walks away. PSV loses its route to recover the asset's value — the very way its business model is built. Second, the player's medical issue is pushed from the internal sphere into the public sphere. Once a failed medical appears in the press, every other club in the system knows. You cannot resell at the old price, because any potential buyer will ask: what happened in Çorum? Third, and perhaps most seriously, a centre-back with a medical issue and only twelve appearances in two years will be labelled by the market. What is that label? Injury-prone. Someone you cannot trust across a long campaign. A bet most clubs do not want to take. There is a prior episode worth recalling. Nagalo went through a long layoff with a shoulder injury. That matters more than it appears. A shoulder injury in a centre-back, in a sport where collisions and aerial duels are daily bread, is not a small thing. It is a signal. And when you add that signal to a current failed medical, you begin to see a pattern — not the pattern of an accident, but the pattern of a body that cannot be trusted. Here, professional ethics must be absolutely clear. I do not know exactly what Nagalo is suffering from. No one outside PSV and the man himself knows. The club has invoked privacy rules to withhold details. That is entirely correct. Under the European Union's data protection framework, health information is the most highly protected category of data. A club has no right — and should not — publish the medical details of a human being. So when I write about Nagalo's body as a market variable, I must simultaneously remind myself that behind that variable is a man in his early twenties, watching his career drift past from the edge of the pitch. I look at the feet, but I listen to the heart. And the heart of a player in this situation usually beats faster than we imagine. The dressing room never lies — only the listener lacks patience. What PSV's dressing room tells us in this case is simple: Nagalo was never part of the core plan. Twelve appearances is hard evidence. And when a player is not part of the core plan, his unavailability creates no gap on the pitch. It creates a gap on the balance sheet. That is the point most football readers miss. We are raised to read football through scores and league tables. But a big European club is not run by scores alone. It is run by cash flow. Every contract is a time-bound investment with an expected return and a risk. And in Nagalo's case, that investment has just lost its near-only remaining exit. The transfer market is only a mirror — look into it and you see the club's fear. If you want to know what PSV fears this summer, look at how they handle the Nagalo case. They fear a stranded asset. They fear a wage continuing to flow to a player who cannot be sold. They fear the moment a starting centre-back gets injured and forces them to rotate in a name they themselves no longer trust. There is one more detail in the file: Nagalo was once loaned to Konyaspor. This is an important piece. It shows PSV already recognised that this player could not develop at Eindhoven the way they had hoped, and they tried to move him out — first on loan, then on a permanent sale. Both times, the route led to Türkiye. That is no coincidence. When a big Western European club cannot sell a player to clubs at its own level or above, it turns to secondary markets. Türkiye is one such market: rich enough to pay wages, ambitious enough to take players from major leagues, but flexible enough to accept profiles the big clubs do not want to touch. Going from PSV down to Konyaspor, then from PSV to FK Çorum, traces a clear downward line on the market map. In football, that is the sign of an unsuccessful signing. A player who develops goes up. A player who does not goes down, and eventually sideways — to smaller markets, shorter contracts, lower fees. There is one possibility De Telegraaf left open. According to that outlet, there is still a chance Nagalo could leave PSV. But this is where you must read transfer news with the eye of someone who has sat through too many quiet training sessions to believe diplomatic statements. When a club says of a player that there is still a chance he leaves, that is usually sales signalling, not information. It is how the selling side keeps the exit route from closing completely, so the market does not turn its back, so potential buyers still have a reason to call. A failed medical changes a player's value in a way no statistical table can measure. It does not just lower the price — it narrows the buyer pool. Clubs willing to absorb medical risk are usually clubs without much money. And clubs without much money usually cannot pay the fee PSV needs to recover its investment. The result is a loop: PSV needs a certain fee to avoid too large a loss, the market can only pay a fraction of that, and everything stands still. At that stage, a big club's realistic options narrow. It can loan him out again, accepting part of the wage, hoping he plays well elsewhere to rebuild value. It can sell cheaply, accepting a book loss to cut future wage costs. Or it can write down the player's value on the balance sheet — an accounting entry admitting the asset is no longer worth what it was. None of those options is painless. And notably, all of them are business decisions, not sporting ones. Contrarian angle: How outsiders misread it Here I want to pause, because there is a common misunderstanding I encounter repeatedly when writing about transfers. When fans read that a player cannot play for medical reasons, the first reaction is often: so what? A back-up, twelve appearances in two years, not playing again this season — what is there to say? PSV still have other centre-backs. The team does not collapse because one man sits out. That is true at the sporting level. But it ignores the most important level of this story. There is a second, subtler misunderstanding: many assume that when a player does not play, the club loses nothing. The opposite is true. A centre-back who does not play still draws a wage. A player who cannot be sold still occupies a registration slot. And an investment that does not return still sits on the books, reminding the leadership of a recruitment decision that went the wrong way. At PSV, a fee of seven million euros against twelve appearances is a ratio no sporting director wants in the year-end report. But what makes this story more thought-provoking is the chain of decisions that led to it. Look at that chain. PSV bought Nagalo for seven million euros. They gave him twelve appearances in two years. They loaned him to Türkiye. They tried to sell him in Türkiye. The sale collapsed at the medical. Now they say there is still a chance he leaves. Each step in that chain is reasonable in isolation. Together, they draw a pattern: a player valued above his real worth, in an environment demanding a readiness greater than he could deliver. And here is the crux I want to stress. The failed medical is not the cause of the problem. It is the symptom. If a player has a medical issue serious enough to block a deal, that issue — large or small — existed before the examination. The real question is not why Çorum refused. The real question is why a player with a shoulder-injury history and only twelve appearances in two years was valued at seven million euros in the first place. That question belongs to the scouting department, not the medical department. And that is why I say this cold story matters more than it appears. It is not a story about an examination. It is a story about a decision-making system. Fairness to PSV is due here. The club is handling this situation entirely professionally. They have not disclosed the player's medical details, something many other clubs have done in the past under media pressure. They have not blamed the player. They have not turned it into a public fight. Their silence is appropriate silence — and sometimes, in football, appropriate silence is the hardest thing to find. That said, one truth remains: a problem does not disappear because no one talks about it. Seven million euros does not disappear. Twelve appearances do not grow. And an asset with no buyer remains an asset with no buyer, whatever name you give it. Throughout my career following clubs, I have learned that the most important decisions at a club rarely happen on the pitch. They happen in air-conditioned meeting rooms, with an Excel sheet open on screen, with a player list and numbers beside each name. At a training ground in Malaysia, I once saw a coach sacked simply because the board needed to cut a wage, not because the team was losing. Football is a business played with feet. But it is decided with numbers. And the Nagalo case is an almost perfect illustration. At the sporting level, it is a small, nearly invisible line of news. At the financial level, it is a real loss, an ongoing wage, a hole on the balance sheet that no one mentions but everyone sees. A season is a symphony — the beat keeper knows when to strike, when to stay silent. PSV are in a moment that demands silence. They do not want noise about this. They do not want it to become a story of failure. But precisely because they are silent, we must listen more carefully. Because in the silence of a big club, there is always a pulse to be heard — if you are patient enough. What I am watching next There will be signals to watch in the coming weeks, and I want to be clear about why I watch them. First, any official statement from PSV on Nagalo's status. Not to learn the medical details — those are not for the public — but to learn where the club places him in its plans. If he disappears from the long-term squad list, that is a signal. Second, any new transfer attempt. The notable thing is not that a club is interested — that will almost certainly happen, since there are always clubs interested in a PSV player. The notable thing is whether a deal reaches the medical stage. If another medical fails, that is nearly the end of the permanent-sale route. Third, any write-down in PSV's financial statements. This is the kind of information most football readers never read. But it is where the story ends. Once a club writes down a player's value in the books, they have publicly admitted that the investment failed. Fourth, and perhaps most important at the sporting level, the fitness of PSV's remaining centre-backs. If one of the main centre-backs is injured during a crucial stretch, Nagalo's value — as a rotation option — rises. But that value only exists if he can play. And as things stand, he cannot. This is the paradox the club must live with: a player who can neither play nor be sold, still on the list as a fixed cost. There is no perfect solution. No tidy ending. Only a next chain of decisions, each trading off something. I once held a printed newspaper in my hands; now I hold a phone, but the pulse of the match does not change. And that pulse — in this case — is not on the pitch. It is in the numbers. It is in a medical examination in central Türkiye, where a young centre-back from Burkina Faso walked in with hope and walked out with nothing changed. Seven million euros is not a small number. But the real story is not that number. The real story is how a big club faces a wrong decision it can no longer undo. No referee blows a whistle for a collapsed deal. No yellow card for a failed investment. Only silence, a balance sheet, and the weeks ahead that none of us can predict. And if there is one thing I want you to carry from this piece, it is this: look at big clubs not when they win, but when they go quiet. Because sometimes, it is precisely in that silence that we hear what they are truly afraid of.